{"id":"additional-challenge-dose","safety":{"commonSideEffects":[{"rate":"null","effect":"Pain, redness, or swelling at the injection site"}]},"_chembl":{"chemblId":"CHEMBL2374170","moleculeType":"Unknown","molecularWeight":"1604.51"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"This is typically done to assess the immune response to a vaccine or to boost immunity in individuals who have not responded adequately to a previous dose. The additional challenge dose is usually administered at a later time point to evaluate the persistence and durability of the immune response.","oneSentence":"Additional challenge dose is used to stimulate the immune system to produce antibodies against a specific antigen.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:18:44.304Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Influenza"}]},"trialDetails":[{"nctId":"NCT07498387","phase":"NA","title":"Management of Catatonic Features in Adolescents With Profound Autism","status":"ACTIVE_NOT_RECRUITING","sponsor":"Tanta University","startDate":"2026-01-01","conditions":"Autism Spectrum Disorder, Catatonia","enrollment":30},{"nctId":"NCT05212610","phase":"PHASE4","title":"Assessing Safety of Coronavirus Infection (COVID-19) Messenger RNA (mRNA) Vaccine Administration in the Setting of a Previous Adverse Reaction","status":"COMPLETED","sponsor":"University of Michigan","startDate":"2022-03-21","conditions":"COVID-19, Corona Virus Infection","enrollment":137},{"nctId":"NCT04801823","phase":"PHASE3","title":"The TreEat Study- Can Early Introduction of Tree Nuts Prevent Tree Nut Allergy in Infants With Peanut Allergy","status":"COMPLETED","sponsor":"Murdoch Childrens Research Institute","startDate":"2021-06-01","conditions":"Food Allergy in Infants, Nut Allergy","enrollment":212},{"nctId":"NCT04478370","phase":"NA","title":"Characterizing Humoral Immune Response to Mosquito Bites","status":"COMPLETED","sponsor":"University of Oxford","startDate":"2021-01-21","conditions":"Malaria, Dengue","enrollment":147},{"nctId":"NCT06845358","phase":"PHASE1","title":"Safety and Challenge Study of BCG TICE(R) Vaccination to Test Tuberculosis Immunity in Heathy Humans","status":"WITHDRAWN","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2025-11-26","conditions":"Tuberculosis","enrollment":""},{"nctId":"NCT02725060","phase":"NA","title":"Autoimmune Basis for Postural Tachycardia Syndrome","status":"ENROLLING_BY_INVITATION","sponsor":"Vanderbilt University Medical Center","startDate":"2016-02","conditions":"Postural Orthostatic Tachycardia Syndrome, Postural Tachycardia Syndrome, Tachycardia","enrollment":58},{"nctId":"NCT07209982","phase":"NA","title":"Dual Task Training Versus Single Task Training in Chronic Hemiplegic Stroke Patients","status":"COMPLETED","sponsor":"University of Lahore","startDate":"2025-01-15","conditions":"Hemiplegia, Hemiplegia Following Ischemic Stroke, Stroke","enrollment":62},{"nctId":"NCT07158619","phase":"NA","title":"Sustained Unresponsiveness (SU) to Cashew Nut Protein Following Oral Allergen-Specific Immunotherapy","status":"NOT_YET_RECRUITING","sponsor":"Medical University of Warsaw","startDate":"2025-09","conditions":"Food Allergy in Children","enrollment":39},{"nctId":"NCT06098144","phase":"PHASE4","title":"Smoking Cessation Program in the Construction Sector","status":"RECRUITING","sponsor":"University of Miami","startDate":"2024-04-10","conditions":"Smoking Cessation, Tobacco Use Cessation, Tobacco Smoking","enrollment":608},{"nctId":"NCT07107451","phase":"NA","title":"Sustained Unresponsiveness (SU) to Sesame Protein Following Low-dose Oral Allergen-specific Immunotherapy","status":"NOT_YET_RECRUITING","sponsor":"Medical University of Warsaw","startDate":"2025-08","conditions":"Food Allergy in Children","enrollment":39},{"nctId":"NCT04744883","phase":"EARLY_PHASE1","title":"Efficacy of Spinal Manipulation Therapy or Mindfulness-based Reduction Therapy on Patients With Chronic Low Back Pain","status":"ACTIVE_NOT_RECRUITING","sponsor":"Rush University Medical Center","startDate":"2020-08-15","conditions":"Chronic Low-back Pain","enrollment":140},{"nctId":"NCT04522791","phase":"PHASE2","title":"Breathing, Relaxation, Attention Training, & Health in Older Adults (BREATHE)","status":"RECRUITING","sponsor":"University of Rochester","startDate":"2020-08-18","conditions":"Mild Cognitive Impairment, Healthy Aging","enrollment":114},{"nctId":"NCT01536522","phase":"EARLY_PHASE1","title":"Asthma Inflammation Research","status":"ENROLLING_BY_INVITATION","sponsor":"The Cleveland Clinic","startDate":"2011-01","conditions":"Asthma, Allergic Asthma, Non-allergic Asthma","enrollment":60},{"nctId":"NCT05683821","phase":"NA","title":"BREATHE 2 Clinic Stop-Smoking Treatment Outreach Study","status":"COMPLETED","sponsor":"University of Wisconsin, Madison","startDate":"2023-07-24","conditions":"Quitting Smoking, Smoking Cessation, Smoking, Cigarette","enrollment":12376},{"nctId":"NCT04658914","phase":"PHASE2","title":"Human Challenge With Live-attenuated Rotavirus to Assess Next-generation Rotavirus Vaccines in Africa","status":"COMPLETED","sponsor":"Centre for Infectious Disease Research in Zambia","startDate":"2021-04-15","conditions":"Diarrhea, Diarrhea Rotavirus","enrollment":720},{"nctId":"NCT04219540","phase":"PHASE4","title":"Long-acting Buprenorphine vs. Naltrexone Opioid Treatments in CJS-involved Adults","status":"COMPLETED","sponsor":"NYU Langone Health","startDate":"2021-01-07","conditions":"Opioid-use Disorder","enrollment":675},{"nctId":"NCT06937918","phase":"NA","title":"Effect of Dynamic Arterial Elastance and Assisted Fluid Management Software Guided Resuscitation in Septic Shock: Pilot Study","status":"RECRUITING","sponsor":"Mahidol University","startDate":"2025-04-23","conditions":"Critical Illness, Fluid Over-load, Dynamic Arterial Elastance","enrollment":60},{"nctId":"NCT05827874","phase":"PHASE1","title":"A Study on the Effect of Nipocalimab on Vaccine Responses in Healthy Participants","status":"COMPLETED","sponsor":"Janssen Research & Development, LLC","startDate":"2023-04-12","conditions":"Healthy","enrollment":32},{"nctId":"NCT06476275","phase":"PHASE1","title":"Single Dose Texas 2017 (H3N2) Challenge Study","status":"COMPLETED","sponsor":"Duke University","startDate":"2024-09-11","conditions":"Influenza Viral Infections","enrollment":33},{"nctId":"NCT06294912","phase":"PHASE1","title":"A Study to Evaluate Antimalarial Activity and Safety of MK-7602 in Healthy Adults (MK-7602-003)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2024-04-18","conditions":"Malaria","enrollment":16},{"nctId":"NCT03668379","phase":"NA","title":"An Adaptive Intervention for Depression Among Latinos Living With HIV","status":"COMPLETED","sponsor":"University of California, San Francisco","startDate":"2020-02-26","conditions":"Depression","enrollment":10},{"nctId":"NCT05523089","phase":"PHASE2","title":"The Effectiveness of CD388 to Prevent Flu in an Influenza Challenge Model in Healthy Adults","status":"COMPLETED","sponsor":"Cidara Therapeutics Inc.","startDate":"2022-09-09","conditions":"Influenza","enrollment":59},{"nctId":"NCT05165212","phase":"PHASE4","title":"Primary Care Amoxicillin Challenge","status":"WITHDRAWN","sponsor":"State University of New York at Buffalo","startDate":"2024-12-31","conditions":"Amoxicillin Allergy","enrollment":""},{"nctId":"NCT04327310","phase":"PHASE1","title":"Clinical Study of Meplazumab to Treat With Malaria","status":"WITHDRAWN","sponsor":"Jiangsu Pacific Meinuoke Bio Pharmaceutical Co Ltd","startDate":"2023-03","conditions":"Malaria (Plasmodium Falciparum)","enrollment":""},{"nctId":"NCT05309772","phase":"NA","title":"The Clinical Impact of the Basophil Activation Test to Diagnose Food Allergy","status":"UNKNOWN","sponsor":"King's College London","startDate":"2023-01-13","conditions":"Food Allergy, Food Allergy in Infants, Food Allergy in Children","enrollment":398},{"nctId":"NCT03916484","phase":"NA","title":"AllyQuest Adherence App Intervention for HIV-positive Men Who Have Sex With Men and Transgender Women: Pilot Trial","status":"COMPLETED","sponsor":"University of North Carolina, Chapel Hill","startDate":"2020-07-08","conditions":"Hiv, HIV/AIDS, Medication Adherence","enrollment":71},{"nctId":"NCT05351671","phase":"PHASE1","title":"A Clinical Study to Determine the Safety, Tolerability and Effect of RLS-0071 Doses When Given to Healthy Adults After Inhaling LPS","status":"COMPLETED","sponsor":"ReAlta Life Sciences, Inc.","startDate":"2022-05-23","conditions":"Healthy","enrollment":30},{"nctId":"NCT04268420","phase":"PHASE1","title":"A Trial For The Study of Falciparum Malaria Protein 013 Administered Via Intramuscular Injection in Healthy Adults","status":"UNKNOWN","sponsor":"U.S. Army Medical Research and Development Command","startDate":"2020-03-20","conditions":"Vaccine Reaction","enrollment":46},{"nctId":"NCT04193150","phase":"","title":"Uncontrolled and Possible Severe Asthma in Denmark","status":"UNKNOWN","sponsor":"Copenhagen University Hospital, Hvidovre","startDate":"2022-10","conditions":"Asthma","enrollment":550},{"nctId":"NCT03617406","phase":"NA","title":"Volume Challenge Added to DSE in the Diagnosis of Severe LFLGAS","status":"COMPLETED","sponsor":"Insel Gruppe AG, University Hospital Bern","startDate":"2018-05-31","conditions":"Aortic Valve Stenosis","enrollment":50},{"nctId":"NCT00357656","phase":"PHASE4","title":"Phase 3/4 Study of a Recombinant Protein-Free Factor VIII (rAHF-PFM): Comparison of Continuous Infusion Versus Intermittent Bolus Infusion in Hemophilia A Subjects Undergoing Major Orthopedic Surgery","status":"COMPLETED","sponsor":"Baxalta now part of Shire","startDate":"2006-05-29","conditions":"Hemophilia A","enrollment":85},{"nctId":"NCT01633840","phase":"NA","title":"New Validated Recipes for Double-blind Placebo-controlled Low Dose Food Challenges","status":"COMPLETED","sponsor":"Christina West","startDate":"2008-09","conditions":"Allergy","enrollment":275},{"nctId":"NCT00866476","phase":"PHASE2","title":"Safety and Efficacy Study of CVD 1208S, a Live, Attenuated Oral Vaccine to Prevent Shigella Infection: Phase IIa","status":"TERMINATED","sponsor":"University of Maryland, Baltimore","startDate":"2010-01","conditions":"Shigella","enrollment":20},{"nctId":"NCT04296279","phase":"PHASE1","title":"A Trial For The Study of Falciparum Malaria Protein 014 Administered Via Intramuscular Injection in Healthy Adults","status":"UNKNOWN","sponsor":"U.S. Army Medical Research and Development Command","startDate":"2020-03-20","conditions":"Vaccine Reaction","enrollment":46},{"nctId":"NCT04641130","phase":"NA","title":"Clinical Validation Study in Allergic Conjunctivitis to Birch Pollen During Allergen Challenge in ALYATEC EEC","status":"COMPLETED","sponsor":"Alyatec","startDate":"2017-07-13","conditions":"Allergic Conjunctivitis","enrollment":16},{"nctId":"NCT03426995","phase":"PHASE1","title":"First-time-in-Human (FTIH) Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single (in Both Fed and Fasted States) or Repeat Doses of GSK3358699","status":"TERMINATED","sponsor":"GlaxoSmithKline","startDate":"2018-03-13","conditions":"Arthritis, Rheumatoid","enrollment":48},{"nctId":"NCT04532164","phase":"PHASE3","title":"Study to Find Out if Cream V61-044 Used to Treat Fungal Infections Causes an Allergic Skin Reaction to Sunlight in Healthy Participants","status":"COMPLETED","sponsor":"Bayer","startDate":"2013-06-10","conditions":"Dermatitis, Photoallergic","enrollment":137},{"nctId":"NCT03162614","phase":"PHASE2","title":"Efficacy, Immunogenicity and Safety Study of GSK Biologicals' Candidate Malaria Vaccine Evaluating Different Dose Schedules in a Sporozoite Challenge Model in Healthy Malaria-naïve Adults","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2017-05-24","conditions":"Malaria","enrollment":154},{"nctId":"NCT03403348","phase":"PHASE1","title":"A First-In-Human Study of Orally Administered JNJ-64417184 to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single and Multiple Ascending Doses, and the Antiviral Activity of Multiple Doses in a Respiratory Syncytial Virus (RSV) Challenge Study in Healthy Participants","status":"COMPLETED","sponsor":"Janssen BioPharma, Inc.","startDate":"2018-05-09","conditions":"Healthy","enrollment":130},{"nctId":"NCT00965055","phase":"PHASE3","title":"Ezetimibe in Patients Hypo-responsive to Statins","status":"TERMINATED","sponsor":"University of California, San Diego","startDate":"2009-09","conditions":"High Cholesterol, Coronary Artery Disease","enrollment":2},{"nctId":"NCT02543086","phase":"PHASE1","title":"Effectiveness of KAE609 in Reducing Asexual & Sexual Blood-stage P.Falciparum Infection & Infectivity to Mosquitos","status":"TERMINATED","sponsor":"Novartis Pharmaceuticals","startDate":"2015-07","conditions":"Plasmodium Falciparum Malaria","enrollment":8},{"nctId":"NCT01739231","phase":"PHASE1, PHASE2","title":"Live Attenuated ETEC Vaccine ACE527 With and Without dmLT Adjuvant in Adults","status":"COMPLETED","sponsor":"PATH","startDate":"2012-09","conditions":"Diarrhea","enrollment":81},{"nctId":"NCT02601716","phase":"PHASE2","title":"PfSPZ Vaccine: Dose Optimization With Heterologous Challenge in Healthy Malaria-Naïve Adults","status":"COMPLETED","sponsor":"Sanaria Inc.","startDate":"2016-01","conditions":"Malaria","enrollment":92},{"nctId":"NCT00875485","phase":"PHASE4","title":"Evaluation of Antibody Persistence & Immune Memory in Subjects Vaccinated During Adolescence With Twinrix™","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2009-05-01","conditions":"Hepatitis B, Hepatitis A","enrollment":210},{"nctId":"NCT02566824","phase":"PHASE4","title":"Cognitive Behavioral Therapy for Adolescents With Attention-Deficit / Hyperactivity Disorder","status":"UNKNOWN","sponsor":"McGill University Health Centre/Research Institute of the McGill University Health Centre","startDate":"2010-10","conditions":"Attention Deficit Hyperactivity Disorder","enrollment":216},{"nctId":"NCT00461097","phase":"PHASE2","title":"Oral Immunotherapy for Childhood Egg Allergy","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2007-05","conditions":"Hypersensitivity, Immediate Hypersensitivity, Food Hypersensitivity","enrollment":55},{"nctId":"NCT00485134","phase":"PHASE1, PHASE2","title":"Shigella Flexneri 2a Invaplex 50 Vaccine Dose Finding and Assessment of Protection","status":"COMPLETED","sponsor":"U.S. Army Medical Research and Development Command","startDate":"2007-05","conditions":"Shigellosis","enrollment":113},{"nctId":"NCT02115516","phase":"PHASE1","title":"Safety and Protective Efficacy of Intravenous Immunization With Cryopreserved Plasmodium Falciparum Sporozoites Under Chemoprophylaxis","status":"COMPLETED","sponsor":"Sanaria Inc.","startDate":"2014-04","conditions":"Malaria, Plasmodium Falciparum Malaria","enrollment":67},{"nctId":"NCT01728701","phase":"PHASE1","title":"Controlled Human Malaria Infection (CHMI) After Immunization With Cryopreserved Plasmodium Falciparum Sporozoites Under Chloroquine Prophylaxis","status":"COMPLETED","sponsor":"Sanaria Inc.","startDate":"2012-09","conditions":"Malaria, Plasmodium Falciparum","enrollment":30},{"nctId":"NCT02213029","phase":"PHASE1","title":"A Study to Evaluate Pharmacokinetics, Pharmacodynamics and Tissue Concentrations of Epelsiban","status":"TERMINATED","sponsor":"GlaxoSmithKline","startDate":"2014-08-28","conditions":"Embryo Transfer","enrollment":33},{"nctId":"NCT00835861","phase":"PHASE2","title":"Effectiveness of Metformin Compared to Insulin in Pregnant Women With Mild Preexisting or Early Gestational Diabetes","status":"COMPLETED","sponsor":"University of North Carolina, Chapel Hill","startDate":"2008-08","conditions":"Non Insulin Dependent Diabetes, Pregnancy","enrollment":31},{"nctId":"NCT01937598","phase":"PHASE3","title":"Antidiabetic Effects of Adding a DPP-4 Inhibitor to Pre-Existing Treatment With an Incretin Mimetic in Patients With T2D","status":"COMPLETED","sponsor":"Michael A. Nauck","startDate":"2013-08","conditions":"Type 2 Diabetes","enrollment":16},{"nctId":"NCT01218984","phase":"PHASE2","title":"ALK21-004: Single-dose Opiate Challenge of Medisorb® Naltrexone (VIVITROL®) in Adults Who Use Opioids","status":"COMPLETED","sponsor":"Alkermes, Inc.","startDate":"2002-03","conditions":"Opiate Dependence","enrollment":27},{"nctId":"NCT01463514","phase":"NA","title":"Noninvasive Determination of Cerebral Tissue Oxygenation in Pulmonary Hypertension","status":"COMPLETED","sponsor":"University of Zurich","startDate":"2011-09","conditions":"Pulmonary Hypertension","enrollment":20},{"nctId":"NCT00857311","phase":"PHASE1","title":"MRKAd5 HIV-1 Gag Vaccine (V520) in Subjects With Chronic Hepatitis C (V520-022) (COMPLETED)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2004-05","conditions":"Hepatitis C","enrollment":17},{"nctId":"NCT01831050","phase":"PHASE4","title":"Safety and Immunogenicity of 1 or 2 Doses of IPV in Latin American Infants Primed With Bivalent OPV Vaccine","status":"COMPLETED","sponsor":"Fidec Corporation","startDate":"2013-05","conditions":"Poliomyelitis","enrollment":1420},{"nctId":"NCT01162473","phase":"EARLY_PHASE1","title":"Milk Oral Immunotherapy in Children to Treat Food Allergy","status":"COMPLETED","sponsor":"Children's Hospital of Philadelphia","startDate":"2010-06","conditions":"Milk Hypersensitivity","enrollment":25},{"nctId":"NCT02237586","phase":"PHASE1","title":"Effect of Plasmodium Falciparum Exposure and Sickle Cell Trait on Infection Rates and Kinetics After IV Administration of PfSPZ Challenge","status":"COMPLETED","sponsor":"Sanaria Inc.","startDate":"2014-07","conditions":"Plasmodium Falciparum Malaria, Malaria","enrollment":25},{"nctId":"NCT01681238","phase":"NA","title":"Goal-directed Therapy in High-risk Surgery","status":"UNKNOWN","sponsor":"Guangzhou First People's Hospital","startDate":"2012-09","conditions":"Perioperative/Postoperative Complications, Hypovolemia, Hypoxia","enrollment":72}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":190,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Additional challenge dose","genericName":"Additional challenge dose","companyName":"GlaxoSmithKline","companyId":"glaxosmithkline","modality":"Biologic","firstApprovalDate":"","aiSummary":"Additional challenge dose is used to stimulate the immune system to produce antibodies against a specific antigen. Used for Influenza.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":1,"withResults":1},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}